APLM
Price:
$0.114
Market Cap:
$12.39M
Apollomics, Inc., a biotechnology company, engages in the discovery and development of oncology therapies to address unmet medical needs in California, Hangzhou, Shanghai, China, and Australia. It develops APL-101 (Vebreltinib), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors; APL-102 is an oral active, small molecule multiple tyrosine kinase inhibitor for liver cancer, breast cancer, and esophageal cancer; and APL-122, a tumor inhibitor candidate to treat cancers within the brain. The company was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated...[Read more]
Industry
Biotechnology
IPO Date
2021-11-26
Stock Exchange
NASDAQ
Ticker
APLM
According to Apollomics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -9082481.00. This represents a change of -108.91% compared to the average of 101.90M of the last 4 quarters.
The mean historical Enterprise Value of Apollomics, Inc. over the last ten years is 683.00M. The current -9082481.00 Enterprise Value has changed -232.98% with respect to the historical average. Over the past ten years (40 quarters), APLM's Enterprise Value was at its highest in in the March 2021 quarter at 3.81B. The Enterprise Value was at its lowest in in the June 2024 quarter at -2014052.72.
Average
683.00M
Median
816.18M
Minimum
44.40M
Maximum
956.76M
Discovering the peaks and valleys of Apollomics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 11.78%
Maximum Annual Enterprise Value = 956.76M
Minimum Annual Increase = -94.88%
Minimum Annual Enterprise Value = 44.40M
Year | Enterprise Value | Change |
---|---|---|
2023 | 44.40M | -94.88% |
2022 | 867.52M | 6.29% |
2021 | 816.18M | 11.78% |
2020 | 730.14M | -23.69% |
The current Enterprise Value of Apollomics, Inc. (APLM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
576.03M
5-year avg
683.00M
10-year avg
683.00M
Apollomics, Inc.’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Apollomics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Apollomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Apollomics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Apollomics, Inc. (APLM)?
What is the 3-year average Enterprise Value for Apollomics, Inc. (APLM)?
What is the 5-year average Enterprise Value for Apollomics, Inc. (APLM)?
How does the current Enterprise Value for Apollomics, Inc. (APLM) compare to its historical average?